What principles should be followed in administering medications to pediatric seminarians, and what side effects can be associated with commonly used drugs? Which is more scientific: single medication or combination medication? The correct choice of drugs is crucial in the medication of pediatric sperm patients.
1. What are the principles of medication for pediatric spermatorrhea patients? Is it better to use a single medication or a combination of medications?
The medication principles for pediatric sperm patients are.
(1) Medication should be started as soon as a child’s diagnosis of schizophrenia is established.
(2) Choose an antipsychotic medication based on the presentation of the child’s clinical symptom cluster, as well as the somatic condition. Treatment is individualized and varies from person to person.
(3) For pediatric patients, treatment should be started with a small dose and gradually increased to the effective recommended dose. The rate of medication adjustment depends on the characteristics of the medication and the child’s physical condition.
(4) Drug therapy should follow the principle of adequate dosage and full course of medication.
If the treatment with one antipsychotic drug has reached the therapeutic dose and the full course of treatment is still ineffective, increase the dose or consider switching to another antipsychotic drug with a different chemical structure as appropriate, and still focus on single drug treatment. If the efficacy of the above treatment is still unsatisfactory, the combination of two drugs should be considered. The combination of two drugs with different chemical structures and different pharmacological effects should be considered. Atypical antipsychotics are generally recommended as the first-line drugs. When treating with antipsychotic drugs, pay attention to monitoring the changes of clinical symptoms and functional impairment, carefully observe and evaluate the adverse drug reactions and make active treatment.
2. There have been three generations of antipsychotic drugs, is it true that the newer the drug, the better its efficacy?
The first generation of antipsychotic drugs are D2 blockers. It can act on four dopamine pathways in the central nervous system, of which D2 receptor blocking effect on the midbrain cortex and midbrain limbic system is its main mechanism of action, but D2 receptor blocking effect on the nodal funnel and nigrostriatal pathway is associated with adverse drug reactions.
Second-generation antipsychotics have higher 5-hydroxytryptamine receptor blocking effects, are more selective in their effects on the limbic system of the midbrain than on the striatal system, and have a smaller or insignificant rate of extrapyramidal adverse effects.
Third-generation antipsychotics are 5-hydroxytryptamine-dopamine system stabilizers, such as aripiprazole. Second- and third-generation antipsychotics are collectively referred to as atypical antipsychotics.
According to the Chinese Guidelines for the Prevention and Treatment of Schizophrenia, atypical antipsychotics are preferred. There is no significant difference in efficacy between the various atypical antipsychotics, but there are individual differences, and the choice needs to be individualized according to the child’s different clinical symptom clusters and somatic conditions. However, haloperidol injections should be considered when the child is uncooperative or markedly excitable and agitated. In cases of poor efficacy with atypical antipsychotics, a switch to or combination with first-generation antipsychotics may be considered. Therefore, it is not the case that the newer the drug, the better the efficacy.
Is it true that the “DA and 5HT dual receptor” theory has been rejected?
We know that non-classical antipsychotics such as clozapine, olanzapine, risperidone, etc. are effective because they act on dopamine (DA) and inhibit 5HT receptors, but now there is a theory that inhibiting 5HT receptors has no significant effect on symptoms. ” doctrine has been discredited, is it true?
Schizophrenia has its own pathological mechanisms, and antipsychotic drugs block both dopamine D2 receptors and possibly 5hydroxytryptamine (5HT) receptors, perhaps acting simultaneously on both. The combined antagonistic effect of second-generation antipsychotics on dopamine and 5HT receptors has been proposed, a feature that also gives it some improvement in negative symptoms and antidepressant effects in children with schizophrenia.
Theoretically, a symptom can be said to be the “target symptom” of a drug if it has its own specific pathological mechanism and there is a drug that can target that pathological mechanism. Likewise, schizophrenia should not be treated with drugs that are specifically designed to treat hallucinations, as in the case of “treating the head when it hurts”. If the positive or negative symptoms do have their own specific pathological mechanisms, then it may be possible to find specific drugs that can treat the positive or negative symptoms separately, with one of them as the “target symptom”. Unfortunately, it has not been possible to elucidate the specific mechanism of each of the positive or negative symptoms. If the negative symptom is indeed frontal hypofunction and a poor dopamine pathway in the frontal lobe, then a drug that selectively increases frontal dopamine would be a specific drug that could target the negative symptom as a “target symptom”. Unfortunately, all existing antipsychotics have the same or similar pharmacological mechanisms, so it is theoretically impossible to have a variety of different “target symptoms. It seems that the problem is not so simple, the so-called dopamine and 5hydroxytryptamine dual receptor theory is not necessarily the truth.
4. In 2012, the US ruled that the manufacturer of Risperidone concealed the side effects of the drug, so what are the side effects of Risperidone?
Indications for child and adolescent psychiatric disorders: Risperidone can be used to treat schizophrenia and also short-term treatment of manic symptoms in patients with bipolar disorder – manic episodes/mixed episodes. Risperidone has been approved by the U.S. FDA for the treatment of irritable symptoms in patients aged 13-17 years with schizophrenia, patients aged 10-17 years with bipolar disorder – manic episodes/mixed episodes in patients aged 5-16 years with autism, etc.
In terms of chemical structure, risperidone is a combination of haloperidol and ritanserin (a 5-hydroxytryptamine receptor blocker), which retains the effects of haloperidol’s D2 receptors while adding the property of blocking 5-hydroxytryptamine receptors. It is thus understandable that risperidone may cause fewer extrapyramidal adverse reactions compared to haloperidol, but in fact it is not as few as early data suggest, and most patients still require benzedrine tablets to counteract them.
Common adverse reactions to risperidone therapy include extrapyramidal adverse effects, dizziness, drowsiness, nausea, and elevated pituitary lactogen, as well as weight gain, anxiety, agitation, insomnia, vomiting, nasal mucositis, erectile dysfunction, lack of orgasm, skin pigmentation, and cardiac conduction dysfunction (e.g., sinus bradycardia). It is also prone to constipation, hepatotoxicity (including steatohepatitis, fatty liver, and elevated transaminases), postural hypotension, elevated blood glucose, type 2 diabetes, and depressed cardiac function reported in children and adolescents.
5.Is pentoxifylline a good drug with good efficacy, cheap price and few side effects? Can it be taken as a first-line drug for a long time?
Pentoxifylline is a long-acting antipsychotic drug with a half-life of 65-70 hours and a duration of action of up to one week, which does not increase body weight and has a low degree of blood sugar increase; although Pentoxifylline has the above characteristics, it does not mean that the drug is effective and has few side effects, Pentoxifylline cannot be used as a first-line drug for all phases of treatment for psychiatric patients, because Pentoxifylline is not effective for all patients, moreover, Pentoxifylline It is an older antipsychotic drug with greater side effects, such as extrapyramidal side effects, especially delayed dyskinesia (TD), which usually appears only after a longer period of time, but once it appears, it is sometimes irreversible and is a serious disabling side effect; moreover, due to the long half-life of pentoxifylline, once the side effects appear, it is troublesome to deal with them because even if the drug is stopped immediately Therefore, it is not recommended as the first-line treatment drug.
Of course, pentoxifylline also has its application, because it is slowly absorbed, slowly acting, so it is difficult to use it to treat acute conditions, it is more suitable for maintenance, to prevent relapse, but it is best to use under the close testing of doctors.